SGK1: A novel target in fibrosis-induced atrial fibrillation

SGK1: A novel target in fibrosis-induced atrial fibrillation

Saved in:

Bibliographic Details
Main Authors:	Alina S. Bilal, Scott A. Hahn, Matthew B. Murphy, Victoria B. Murray, Katherine T. Murray, Christopher C. Glembotski, Erik A. Blackwood
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Journal of Molecular and Cellular Cardiology Plus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772976125001138
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IRE1α protects against cardiac fibrosis via selective degradation of a profibrotic transcriptome
by: Ernie Sandoval, et al.
Published: (2025-06-01)

SNAP23 is a Novel Regulator of Autophagy in Cardiac Myocytes
by: Sean Noudali, et al.
Published: (2025-06-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
by: Christian Mahnkopf, et al.
Published: (2021-12-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Assessment of the Degree of Left Atrial Fibrosis in Patients with Different Forms of Atrial Fibrillation
by: Eugene O. Perepeka, et al.
Published: (2025-06-01)

Effects of Doxorubicin on Fibrotic Remodeling in the Heart
by: Sukriti Bagchi, et al.
Published: (2025-06-01)

Unraveling the Potential of SGK1 in Osteoporosis: From Molecular Mechanisms to Therapeutic Targets
by: Fei Yang, et al.
Published: (2025-05-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Glutathione peroxidase 4 as a potential biomarker for atrial fibrosis and recurrence of atrial fibrillation
by: Tong Liu, MD, et al.
Published: (2025-05-01)

Atrial Fibrillation Begets Atrial Fibrillation in Small Animals: Characterization of New Rat Model of Spontaneous Atrial Fibrillation
by: Alkora Ioana Balan, et al.
Published: (2025-03-01)

Knockdown of AMFR Alleviates Atrial Fibrosis in Atrial Fibrillation by Stabilizing SOD1 Protein Expression
by: Shanshan Geng MD, et al.
Published: (2025-07-01)

Targeting atrial fibrillation in HFpEF: the emerging role of pulsed field ablation
by: A. S. Parwani, et al.
Published: (2025-07-01)

Paroxysmal atrial fibrillation (part II)
by: B. A. Tatarsky
Published: (2008-06-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

“Pill in the pocket” strategy for atrial fibrillation treatment
by: B. A. Tatarsky
Published: (2005-08-01)

Paroxysmal forms of atrial fibrillation (part 1)
by: B. A. Tatarsky
Published: (2008-04-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

ACE inhibitors in the treatment of paroxysmal atrial fibrillation
by: B. A. Tatarsky
Published: (2005-06-01)

Comparative evaluation of markers of inflammation and fibrosis in patients with various clinical forms of atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-12-01)

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?
by: V. A. Ionin, et al.
Published: (2021-08-01)

Ultrasound assessment of the association between left atrial remodeling and fibrosis in patients with valvular atrial fibrillation: a clinical investigation
by: Tao Xu, et al.
Published: (2025-03-01)

Atrial Fibrillation
by: Natig Gassanov, et al.
Published: (2013-01-01)

Morpholino gene knockdown in adult Fundulus heteroclitus: role of SGK1 in seawater acclimation.
by: Emily G Notch, et al.
Published: (2011-01-01)

Screening for atrial fibrillation after stroke: is targeted patient selection the key?
by: Thaís Leite Secchi, et al.
Published: (2024-10-01)

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
by: M. G. Arakelyan, et al.
Published: (2021-08-01)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022-01-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

Adaptive variation regulates the expression of the human SGK1 gene in response to stress.
by: Francesca Luca, et al.
Published: (2009-05-01)

SGK1 drives hippocampal demyelination and diabetes-associated cognitive dysfunction in mice
by: Ziying Jiang, et al.
Published: (2025-02-01)

The correlation between serum SGK1 and vascular calcification in maintenance hemodialysis patients
by: YAO Dan-dan, et al.
Published: (2020-01-01)

Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea
by: V. A. Berdysheva, et al.
Published: (2025-01-01)

Atrial fibrillation in the Americas
by: Jason G. Andrade, et al.
Published: (2025-07-01)

Adipose stem cell-derived exosomes circular RNA circFryl attenuate atrial fibrosis and cardiomyocyte apoptosis in atrial fibrillation
by: Chunpu Li, et al.
Published: (2025-09-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Synthetic fibrosis distributions for data augmentation in predicting atrial fibrillation ablation outcomes: an in silico study
by: Alexander M. Zolotarev, et al.
Published: (2025-04-01)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
by: Mengdi Ren, et al.
Published: (2021-01-01)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016-06-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)